In Vivo is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Chinese CRO ShangPharma Corp. has netted $44.7mm through its initial public offering of 3.2mm American Depositary Shares at $15 each, on the lower end of the company's $14.50-16.50 range. Each ADS represents 18 ordinary shares. Existing shareholders have also sold 2.6mm ADSs.
Contract Research, Toxicology Testing-CRO
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?